Moreover, BUB1, CCNB1, BUB1B, ISG15, KIF11, CDC20, TTK, and NCAPG showed prognostic value and potential roles in assessment of the efficacy of BC immunotherapy. This evidence concerns the gene TTK and breast cancer.